{"organizations": [], "uuid": "d612d258424839ee731dcbb1fcc79ce4ba993742", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180208.html", "section_title": "Archive News &amp; Video for Thursday, 08 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-emerald-health-therapeutics-announ/brief-emerald-health-therapeutics-announces-18-mln-prospectus-sale-idUSFWN1PY11Y", "country": "US", "domain_rank": 408, "title": "BRIEF-Emerald Health Therapeutics Announces $18 Mln Prospectus Sale", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.548, "site_type": "news", "published": "2018-02-08T21:21:00.000+02:00", "replies_count": 0, "uuid": "d612d258424839ee731dcbb1fcc79ce4ba993742"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-emerald-health-therapeutics-announ/brief-emerald-health-therapeutics-announces-18-mln-prospectus-sale-idUSFWN1PY11Y", "ord_in_thread": 0, "title": "BRIEF-Emerald Health Therapeutics Announces $18 Mln Prospectus Sale", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-emerald health therapeutics", "sentiment": "negative"}, {"name": "mln prospectus sale feb", "sentiment": "negative"}, {"name": "reuters) - emerald health therapeutics inc", "sentiment": "neutral"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 8 (Reuters) - Emerald Health Therapeutics Inc:\n* EMERALD HEALTH THERAPEUTICS ANNOUNCES $18 MILLION PROSPECTUS SALE; CONCURRENT SECONDARY SALE\n* EMERALD HEALTH THERAPEUTICS INC - ENTERED INTO A BINDING TERM SHEET WITH A SINGLE CANADIAN INSTITUTIONAL ACCREDITED INVESTOR\n* EMERALD HEALTH THERAPEUTICS INC - INVESTOR AGREED TO PURCHASE 3 MILLION UNITS OF COMPANY AT A PRICE OF $6.00 PER UNIT Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-08T21:21:00.000+02:00", "crawled": "2018-02-09T17:00:21.000+02:00", "highlightTitle": ""}